117 related articles for article (PubMed ID: 36202742)
21. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
Cuff RD; Sullivan SA; Chang EY
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
[No Abstract] [Full Text] [Related]
22. Magnesium sulfate exposure and neonatal intensive care unit admission at term.
Girsen AI; Greenberg MB; El-Sayed YY; Lee H; Carvalho B; Lyell DJ
J Perinatol; 2015 Mar; 35(3):181-5. PubMed ID: 25321647
[TBL] [Abstract][Full Text] [Related]
23. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.
Havranek T; Ashmeade TL; Afanador M; Carver JD
Neonatology; 2011; 100(1):44-9. PubMed ID: 21212694
[TBL] [Abstract][Full Text] [Related]
24. Correlation between magnesium sulphate exposure in utero and serum calcium and alkaline phosphatase levels in preterm infants.
Kuraaki A; Shoko MU; Kazuhiro A
Magnes Res; 2022 Oct; 35(4):118-124. PubMed ID: 37052150
[TBL] [Abstract][Full Text] [Related]
25. Effect of magnesium sulfate treatment on neonatal bone abnormalities.
Matsuda Y; Maeda Y; Ito M; Sakamoto H; Masaoka N; Takada M; Sato K
Gynecol Obstet Invest; 1997; 44(2):82-8. PubMed ID: 9286718
[TBL] [Abstract][Full Text] [Related]
26. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
27. Delayed meconium passage in very low birth weight infants.
Arnoldi R; Leva E; Macchini F; Di Cesare A; Colnaghi M; Fumagalli M; Mosca F; Torricelli M
Eur J Pediatr Surg; 2011 Dec; 21(6):395-8. PubMed ID: 22169992
[TBL] [Abstract][Full Text] [Related]
28. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
[TBL] [Abstract][Full Text] [Related]
29. Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU.
Ayed M; Ahmed J; More K; Ayed A; Husain H; AlQurashi A; Alrajaan N
Biomed Hub; 2022; 7(2):80-87. PubMed ID: 35950015
[TBL] [Abstract][Full Text] [Related]
30. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
31. Effects of Antenatal Magnesium Sulfate on the Gut Function of Preterm (<32 weeks) Very Low Birth Weight Neonates: Experience from a Tertiary Institute in South India.
Chandran S; Tergestina M; Ross B; Joshi A; Rebekah G; Kumar M
J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34100090
[TBL] [Abstract][Full Text] [Related]
32. Timing of administration of antenatal magnesium sulfate and umbilical cord blood magnesium levels in preterm babies.
Reynolds A; Slattery S; Byrne S; Neary E; Müllers S; Kent E; Malone FD; El-Khuffash A; McGarvey C; Hayes BC
J Matern Fetal Neonatal Med; 2019 Mar; 32(6):1014-1019. PubMed ID: 29082790
[TBL] [Abstract][Full Text] [Related]
33. Time of passage of first stools (meconium) and serum levels of calcium and magnesium in Nigerian neonates (African neonates).
Omoigberale AI; Okolo AA
Niger J Clin Pract; 2009 Mar; 12(1):54-7. PubMed ID: 19562923
[TBL] [Abstract][Full Text] [Related]
34. Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
Jonsdotter A; Rocha-Ferreira E; Hagberg H; Carlsson Y
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):856-861. PubMed ID: 35501953
[TBL] [Abstract][Full Text] [Related]
35. [Preeclampsia and benefit form magnesium sulfate. About 105 cases].
Naeimi A; Rieu M; Le Guen F; Marpeau L
Gynecol Obstet Fertil; 2014 May; 42(5):322-4. PubMed ID: 23157847
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
Ow LL; Kennedy A; McCarthy EA; Walker SP
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
[TBL] [Abstract][Full Text] [Related]
37. Effects of maternal magnesium sulfate treatment on newborns.
Numoto S; Kakita H; Takeshita S; Ueda H; Kondo T; Kurahashi H; Wakatsuki A; Yamada Y; Okumura A
Pediatr Int; 2022 Jan; 64(1):e14747. PubMed ID: 33904213
[TBL] [Abstract][Full Text] [Related]
38. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
39. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting maternal serum magnesium levels during long-term magnesium sulfate tocolysis in singleton and twin pregnancy.
Nakazawa H; Uchida A; Minamitani T; Makishi A; Takamatsu Y; Kiyoshi K; Samoto T; Funakoshi T
J Obstet Gynaecol Res; 2015 Aug; 41(8):1178-84. PubMed ID: 25857633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
